Survival Benefits of Statins in Breast Cancer Patients
Status:
Recruiting
Trial end date:
2024-06-28
Target enrollment:
Participant gender:
Summary
In this study, we compared the survival benefit of breast cancer patients with dyslipidemia
(low and medium risk of ASCVD). The control group used dietary intervention instead of
statins intervention. The main endpoint was 5 years DFS. The subjects were breast cancer
patients.